Le Lézard
Classified in: Health, Business
Subjects: ERN, CCA

Invesque Announces Details of Third Quarter 2021 Earnings Conference Call


TORONTO, Oct. 12, 2021 /CNW/ - Invesque Inc. (TSX: IVQ.U) (TSX: IVQ) (the "Company") will release its third quarter 2021 results on Wednesday, November 10, 2021, after markets close. Management of the Company will hold a conference call at 10:00 a.m. ET on Thursday, November 11, 2021, to review the financial results.      

CONFERENCE CALL DETAILS:

DATE:

Thursday, November 11, 2021

TIME:

10:00 a.m. ET

DIAL IN NUMBER:

647-792-1240

1-866-248-8441

CONFERENCE ID:

8751781

WEBCAST:

Available at http://www.invesque.com/company-presentations/. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived on the Company's website following the call date.  

TAPED REPLAY:

647-436-0148 or 1-888-203-1112

Available from 12:45 p.m. ET on November 11, 2021, until 11:59 p.m. ET on November 18, 2021.

REFERENCE NUMBER:

8751781

ABOUT INVESQUE:
Invesque is a North American health care real estate company with an investment thesis focused on the premise that an aging demographic in North America will continue to utilize health care services in growing proportion to the overall economy. Invesque currently capitalizes on this opportunity by investing in a highly diversified portfolio of income generating properties across the health care spectrum. Invesque's portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care and medical office properties, which are operated primarily under long-term leases and joint venture arrangements with industry leading operating partners. Invesque's portfolio also includes investments in owner-occupied seniors housing properties in which Invesque owns the real estate and provides management services through its subsidiary management company, Commonwealth Senior Living. For more information, please visit www.invesque.com.

SOURCE Invesque Inc.


These press releases may also interest you

at 10:30
The "Licensing Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully...

at 10:30
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. Exciting technical...

at 10:10
The group division of Ameritas proudly announces its 17th consecutive certification as a BenchmarkPortal Center of Excellence, solidifying its position as a leader in customer service and support excellence. This prestigious recognition for 2023...

at 10:05
The "Distribution Deals in Diagnostics 2016 to 2024" report has been added to ResearchAndMarkets.com's offering. Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution deals....

at 10:00
Driving is the leading cause of work-related death each year in the United States, with nearly 40% of deaths on the job occurring on American roads according to the U.S. Bureau of Labor Statistics. A major contributing factor to road deaths each...

at 10:00
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Methimazole Tablets, USP, 5 mg and 10 mg. The Methimazole Tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according...



News published on and distributed by: